Hernando Salazar

1.4k total citations
47 papers, 1.1k citations indexed

About

Hernando Salazar is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Hernando Salazar has authored 47 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 11 papers in Molecular Biology and 8 papers in Surgery. Recurrent topics in Hernando Salazar's work include Wnt/β-catenin signaling in development and cancer (6 papers), Higher Education and Sustainability (3 papers) and Polyomavirus and related diseases (3 papers). Hernando Salazar is often cited by papers focused on Wnt/β-catenin signaling in development and cancer (6 papers), Higher Education and Sustainability (3 papers) and Polyomavirus and related diseases (3 papers). Hernando Salazar collaborates with scholars based in United States, Colombia and India. Hernando Salazar's co-authors include Aaron C. Han, Karen A. Knudsen, Alejandro Peralta Soler, Héctor Tobón, Albert A. Keshgegian, Robert S. Totten, Anisa Kanbour, Chik‐Kwun Tang, Amador González-Angulo and Norman G. Rosenblum and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Hernando Salazar

42 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hernando Salazar United States 21 454 277 253 145 121 47 1.1k
G Vinci France 24 566 1.2× 80 0.3× 158 0.6× 107 0.7× 62 0.5× 43 1.7k
Janet M. Cowan United States 25 1.1k 2.4× 508 1.8× 233 0.9× 139 1.0× 140 1.2× 56 2.0k
Markus M. Valter Germany 16 338 0.7× 202 0.7× 120 0.5× 82 0.6× 85 0.7× 25 1.2k
Christiane Gerlach Germany 9 340 0.7× 295 1.1× 199 0.8× 202 1.4× 23 0.2× 13 1.1k
Annikki Liakka Finland 16 376 0.8× 249 0.9× 66 0.3× 101 0.7× 104 0.9× 24 1.3k
H Salazar United States 12 368 0.8× 120 0.4× 173 0.7× 53 0.4× 53 0.4× 16 765
Patricia Bourne United States 22 552 1.2× 529 1.9× 424 1.7× 315 2.2× 31 0.3× 46 1.7k
Kimitoshi Imai Japan 21 241 0.5× 284 1.0× 82 0.3× 78 0.5× 225 1.9× 40 1.2k
I.-M. Shih United States 11 343 0.8× 182 0.7× 50 0.2× 51 0.4× 87 0.7× 15 768
Karen D. Cowden Dahl United States 15 678 1.5× 277 1.0× 93 0.4× 72 0.5× 124 1.0× 26 1.1k

Countries citing papers authored by Hernando Salazar

Since Specialization
Citations

This map shows the geographic impact of Hernando Salazar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hernando Salazar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hernando Salazar more than expected).

Fields of papers citing papers by Hernando Salazar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hernando Salazar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hernando Salazar. The network helps show where Hernando Salazar may publish in the future.

Co-authorship network of co-authors of Hernando Salazar

This figure shows the co-authorship network connecting the top 25 collaborators of Hernando Salazar. A scholar is included among the top collaborators of Hernando Salazar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hernando Salazar. Hernando Salazar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Siau, Evan, et al.. (2019). Non-oncologist Physician Knowledge of Radiation Therapy at an Urban Community Hospital. Journal of Cancer Education. 36(1). 199–206. 2 indexed citations
3.
Salazar, Hernando, et al.. (2019). Bergeyella zoohelcum Bacteremia from Therapy Dog Kisses. Cureus. 11(4). e4494–e4494. 2 indexed citations
4.
Salazar, Hernando, et al.. (2018). Una década de economía social y solidaria en Colombia. Análisis de la producción investigativa y académica 2005 - 2015.. 6 indexed citations
5.
Salazar, Hernando. (2016). Economía agraria y asociatividad cooperativa en Colombia. 1 indexed citations
6.
Salazar, Hernando & Robert E. Scully. (2000). The International Society of Gynecological Pathologists. International Journal of Gynecological Pathology. 19(1). 3–6. 3 indexed citations
7.
Han, Aaron C., Mitchell I. Edelson, Alejandro Peralta Soler, et al.. (2000). Cadherin expression in glandular tumors of the cervix. Cancer. 89(10). 2053–2058. 26 indexed citations
8.
Han, Aaron C., et al.. (1999). N-cadherin distinguishes pleural mesotheliomas from lung adenocarcinomas. Cancer. 87(2). 83–86. 28 indexed citations
9.
Soler, Alejandro Peralta, Karen A. Knudsen, Hernando Salazar, Aaron C. Han, & Albert A. Keshgegian. (1999). P‐cadherin expression in breast carcinoma indicates poor survival. Cancer. 86(7). 1263–1272. 28 indexed citations
10.
Soler, Alejandro Peralta, Karen A. Knudsen, Hernando Salazar, Aaron C. Han, & Albert A. Keshgegian. (1999). P-cadherin expression in breast carcinoma indicates poor survival. Cancer. 86(7). 1263–1272. 125 indexed citations
11.
Han, Aaron C., Alejandro Peralta Soler, Karen A. Knudsen, & Hernando Salazar. (1999). Distinct cadherin profiles in special variant carcinomas and other tumors of the breast. Human Pathology. 30(9). 1035–1039. 53 indexed citations
12.
Ranganathan, Sulabha, Hernando Salazar, Christopher A. Benetatos, & Gary R. Hudes. (1997). Immunohistochemical analysis of β-tubulin isotypes in human prostate carcinoma and benign prostatic hypertrophy. The Prostate. 30(4). 263–268. 36 indexed citations
14.
Hoffman, John P., et al.. (1996). Preoperative chemoradiotherapy for localized pancreatic carcinoma: A perspective. Cancer. 78(3). 592–597. 15 indexed citations
15.
Soler, Alejandro Peralta, Karen A. Knudsen, & Hernando Salazar. (1996). Reply. Human Pathology. 27(11). 1246–1246. 1 indexed citations
16.
Thrash-Bingham, Catherine, Hernando Salazar, Richard E. Greenberg, & Kenneth D. Tartof. (1996). Loss of heterozygosity studies indicate that chromosome arm 1p harbors a tumor suppressor gene for renal oncocytomas. Genes Chromosomes and Cancer. 16(1). 64–67. 38 indexed citations
17.
Berman, Michael L., Suzanne Bergen, & Hernando Salazar. (1990). Influence of histological features and treatment on the prognosis of patients with cervical cancer metastatic to pelvic lymph nodes. Gynecologic Oncology. 39(2). 127–131. 16 indexed citations
18.
Salazar, Hernando, Ronald A. Chez, & Matias Pardo. (1973). Absence of ultrastructural changes in the basement membrane of muscle capillaries in streptozotocin-induced carbohydrate intolerance in rhesus monkeys.. PubMed. 71(3). 437–46. 12 indexed citations
19.
Salazar, Hernando & Roy R. Peterson. (1964). Morphologic observations concerning the release and transport of secretory products in the adenohypophysis. American Journal of Anatomy. 115(2). 199–215. 20 indexed citations
20.
Salazar, Hernando. (1963). The pars distalis of the female rabbit hypophysis: An electron microscopic study. The Anatomical Record. 147(4). 469–497. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026